Correlation Between US Bancorp and Pfizer
Can any of the company-specific risk be diversified away by investing in both US Bancorp and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining US Bancorp and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between US Bancorp and Pfizer Inc, you can compare the effects of market volatilities on US Bancorp and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in US Bancorp with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of US Bancorp and Pfizer.
Diversification Opportunities for US Bancorp and Pfizer
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between USB and Pfizer is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding US Bancorp and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and US Bancorp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on US Bancorp are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of US Bancorp i.e., US Bancorp and Pfizer go up and down completely randomly.
Pair Corralation between US Bancorp and Pfizer
Considering the 90-day investment horizon US Bancorp is expected to generate 1.24 times more return on investment than Pfizer. However, US Bancorp is 1.24 times more volatile than Pfizer Inc. It trades about -0.19 of its potential returns per unit of risk. Pfizer Inc is currently generating about -0.31 per unit of risk. If you would invest 4,395 in US Bancorp on January 29, 2024 and sell it today you would lose (283.00) from holding US Bancorp or give up 6.44% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
US Bancorp vs. Pfizer Inc
Performance |
Timeline |
US Bancorp |
Pfizer Inc |
US Bancorp and Pfizer Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with US Bancorp and Pfizer
The main advantage of trading using opposite US Bancorp and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if US Bancorp position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.US Bancorp vs. PNC Financial Services | US Bancorp vs. KeyCorp | US Bancorp vs. Zions Bancorporation | US Bancorp vs. Fifth Third Bancorp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |